Checkpoint Capital »

Corcept Therapeutics Incorporated shares owned by Checkpoint Capital

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Checkpoint Capital from 13F filings

Historical chart of Checkpoint Capital investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Checkpoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Checkpoint Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.9M 274k 25.19

More positions owned by Checkpoint Capital

Rhythm Pharmaceuticals (RYTM)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Axsome Therapeutics (AXSM)
Mirum Pharmaceuticals (MIRM)
Protagonist Therapeutics (PTGX)
Corcept Therapeutics Incorporated (CORT)
Ironwood Pharmaceuticals Com Cl A (IRWD)
Phathom Pharmaceuticals (PHAT)
Atyr Pharma Com New (LIFE)
Verastem Com New (VSTM)
Gh Research Ordinary Shares (GHRS)
Trevi Therapeutics (TRVI)
Applied Therapeutics (APLT)

View all positions for Checkpoint Capital

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Parallel Advisors
Dimensional Fund Advisors
Geode Capital Management
First Trust Advisors
Btim
Federated Investors
Arrowstreet Capital, Limited Partnership
Morgan Stanley
Man Group
Susquehanna International
Ikarian Capital
Millennium Management

View all funds holding Corcept Therapeutics Incorporated